FcyRIIB is a novel immune checkpoint in the tumor microen... | ResearchHubFcyRIIB is a novel immune checkpoint in the tumor microenvironment limiting activity of Treg-targeting antibodies
ByDavid Knorr·Rom Leidner·Jeffrey Ravetch Preprint January 20, 2023